newsfilter
← Latest News
GlobeNewswire·

Sonnet BioTherapeutics Holdings, Inc. Announces Stockholder Approval of Proposed Business Combination with Hyperliquid Strategies Inc

PRINCETON, N.J., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc., (NASDAQ:SONN) ("Sonnet" or the "Company") today announced that its stockholders approved, among other things, the proposed